Search

Your search keyword '"Robert P. Hebbel"' showing total 246 results

Search Constraints

Start Over You searched for: Author "Robert P. Hebbel" Remove constraint Author: "Robert P. Hebbel"
246 results on '"Robert P. Hebbel"'

Search Results

1. Relationship of Endothelial Microparticles to Obesity and Cardiovascular Disease Risk in Children and Adolescents

2. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease

Catalog

Books, media, physical & digital resources

3. Relationship of Circulating Endothelial Cells With Obesity and Cardiometabolic Risk Factors in Children and Adolescents

5. Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer

6. Abnormal Endothelial Gene Expression Associated With Early Coronary Atherosclerosis

7. Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells

8. Multiple inducers of endothelial<scp>NOS</scp>(<scp>eNOS</scp>) dysfunction in sickle cell disease

9. Reproducibility of endothelial microparticles in children and adolescents

12. Abstract P031: Endothelial Microparticles In Pediatric Obesity

13. Targeting AnxA1/Fpr2/ALX Regulates Neutrophil Function Promoting Thrombo-Inflammation Resolution in Sickle Cell Disease

14. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease

16. Relationship of Circulating Endothelial Cells With Obesity and Cardiometabolic Risk Factors in Children and Adolescents

17. Abnormal Endothelial Gene Expression Associated With Early Coronary Atherosclerosis

18. Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer

19. A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade

20. Specific Correction of the Intron-22 Inverted Factor VIII Gene in Autologous Blood Outgrowth Endothelial Cells from Patients with Severe Hemophilia A

21. Morphine promotes neovascularizing retinopathy in sickle transgeneic mice

22. Reproducibility of circulating endothelial cell enumeration and activation in children and adolescents

23. Blood endothelial cells: utility from ambiguity

24. Blood outgrowth endothelial cells overexpressing eNOS mitigate pulmonary hypertension in rats: a unique carrier cell enabling autologous cell-based gene therapy

25. The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers

26. Contributors

27. Pathobiology of Sickle Cell Disease

28. Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks

29. Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study

30. Ischemia-reperfusion Injury in Sickle Cell Anemia

31. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease

32. Poly (lactic acid)–chitosan–collagen composite nanofibers as substrates for blood outgrowth endothelial cells

33. Pilot study of vascular health in survivors of osteosarcoma

34. Establishment of outgrowth endothelial cells from peripheral blood

35. Pilot study of vascular health in survivors of Hodgkin lymphoma

36. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness

37. Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula

38. Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S

39. Circulating Activated Endothelial Cells in Pediatric Obesity

40. Longitudinal follow-up of endothelial function in breast cancer survivors on aromatase inhibitors (AIs)

41. Nuclear factor-kappa B (NFκB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease

42. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

43. A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis

44. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease

45. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

46. Blood outgrowth endothelial cell migration and trapping in vivo: a window into gene therapy

47. Genetic endothelial systems biology of sickle stroke risk

48. A PRACTICAL QUESTION BASED ON CROSS-PLATFORM MICROARRAY DATA NORMALIZATION: ARE BOEC MORE LIKE LARGE VESSEL OR MICROVASCULAR ENDOTHELIAL CELLS OR NEITHER OF THEM?

49. Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy

50. The establishment of murine blood outgrowth endothelial cells and observations relevant to gene therapy